CELLINK FIBRIN

$480

Based on CELLINK Bioink, CELLINK FIBRIN contains contains Nanofibrillated Cellulose, jointly patented by UPM-Kymmene Corporation and CELLINK Bioprinting. Additionally, this bioink includes fibrinogen that is converted into a fibrin network with thrombin-containing crosslinking solution after printing.

Quantity
SKU: IKC206000301 Categories: , Tags: ,

Description

These nanosized fibrils make the bioink semi-translucent which allows cell imaging and analysis. Additionally, this bioink includes fibrinogen that is converted into a fibrin network with thrombin-containing crosslinking solution after printing. This in situ fibrin protein network provides a physiologically relevant wound-healing environment that mimics blood clotting and supports vascularization.

CELLINK FIBRIN contains low levels of endotoxins that allows creation of healthy and diseased tissue models with minimal interference with drugs during drug discovery and development research.

  • Shelf life: minimum 3 months.
  • Storage conditions: 2-10°C, do not freeze.
  • Includes CaCl2 Crosslinking Agent and thrombin.
  • For research use only. Not for human use.

Specifications

Appearance White semi-translucent gel
Sterility Sterile
Endotoxin level <5 EU/mL
pH 6.5-7.4
Viscosity 2.6-7.5 kPa∙s at 0.01 s-1; 1.0-1.9 Pa∙s at 200 s-1

Publications

3D Co-Printing and Substrate Geometry Influence the Differentiation of C2C12 Skeletal Myoblasts
Loi, G; Scocozza, F; Aliberti, F; Rinvenuto, L; Cidonio, G; Marchesi, N; Benedetti, L; Ceccarelli, G; Conti, M. Gels (Basel, Switzerland), 9(7), 595. (2023)
https://doi.org/10.3390/gels9070595

Myoblast 3D bioprinting to burst in vitro skeletal muscle differentiation
Ronzoni, FL; Aliberti, F; Scocozza, F; Benedetti, L; Auricchio, F; Sampaolesi, M; Cusella, G; Redwan, IN; Ceccarelli, G; Conti, M. Journal of Tissue Engineering and Regenerative Medicine, 16(5), 484–495. (2022)
https://doi.org/10.1002/term.3293

Printing support hydrogels for creating vascular‑like structures in stacked cell sheets
Tanaka, R. I; Sakaguchi, K; Umezu, S. Artificial Life and Robotics, 25(2), 199–203. (2020)
https://doi.org/10.1007/s10015-020-00605-7

Resources

Documents

You may also like…

  • GelXA FIBRIN

    GelXA FIBRIN

    Based on our GelXA Bioink, GelXA FIBRIN contains f...
    $1,250
  • GelMA FIBRIN

    GelMA FIBRIN

    GelMA FIBRIN bioink with incorporated fibrinogen, ...
    $425
  • CELLINK Bioink

    CELLINK Bioink

    CELLINK Bioink is composed of non-animal derived p...
    $435